← Back to Clinical Trials
Recruiting NCT07078890

NCT07078890 Effect of Bone Augmentation Simultaneous to Implant Removal on the Prognosis of Reimplantation at the Same Site

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07078890
Status Recruiting
Phase
Sponsor The Dental Hospital of Zhejiang University School of Medicine
Condition Implant Failure
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-03-12
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
bone augmentation simultaneous to implant removal

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-03-12 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study was to investigate the effect of bone augmentation simultaneous to implant removal on the prognosis of reimplantation at the same sites, providing recommendations for management strategies after failed implant removal.

Eligibility Criteria

Inclusion Criteria: * 1\. Age greater than 18 years 2. Implant failure requiring removal 3. Plan to reimplant in the same site 4. Periodontal health, or stabilized periodontitis after treatment Exclusion Criteria: * 1\. Uncontrolled metabolic diseases 2. Taking medications that have an effect on bone metabolism 3. The implant has detached at the time of consultation 4. Do not consent to reimplant in the same site 5. Unwillingness to participate in the follow-up of this study 6. Other conditions that do not qualify for implant therapy

Contact & Investigator

Central Contact

Misi Si

✉ misi_si@zju.edu.cn

📞 +86 18605712858

Frequently Asked Questions

Who can join the NCT07078890 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Implant Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07078890 currently recruiting?

Yes, NCT07078890 is actively recruiting participants. Contact the research team at misi_si@zju.edu.cn for enrollment information.

Where is the NCT07078890 trial being conducted?

This trial is being conducted at Wuhan, China, Hangzhou, China, Shanghai, China.

Who is sponsoring the NCT07078890 clinical trial?

NCT07078890 is sponsored by The Dental Hospital of Zhejiang University School of Medicine. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology